Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 10/20 | 0.73 |
| ▸ | USP2 | O75604 | 6/20 | 0.73 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.73 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.73 |
| ▸ | TSHR | P16473 | 1/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.72 |
| ▸ | L3MBTL1 | Q9Y468 | 7/20 | 0.72 |
| ▸ | MMP2 | P08253 | 1/20 | 0.72 |
| ▸ | MMP3 | P08254 | 1/20 | 0.72 |
| ▸ | MMP7 | P09237 | 1/20 | 0.72 |
| ▸ | MMP8 | P22894 | 1/20 | 0.72 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.72 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.72 |
| ▸ | MMP13 | P45452 | 1/20 | 0.72 |
| ▸ | RECQL | P46063 | 7/20 | 0.67 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.67 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.67 |
| ▸ | HPGD | P15428 | 7/20 | 0.48 |
| ▸ | MEN1 | O00255 | 6/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23005369 | 1.00 | TDP1 (0.73) | TDP1USP2HSD17B10HIF1ATSHR | |
| SCHEMBL21014939 | 1.00 | TDP1 (0.73) | TDP1USP2HSD17B10HIF1ATSHR | |
| SCHEMBL4082642 | 1.00 | TDP1 (0.73) | TDP1USP2HSD17B10HIF1ATSHR | |
| SCHEMBL4082631 | 1.00 | TDP1 (0.73) | TDP1USP2HSD17B10HIF1ATSHR | |
| SCHEMBL1176275 | 1.00 | TDP1 (0.73) | TDP1USP2HSD17B10HIF1ATSHR | |
| Water SCHEMBL1649970 | 0.99 | MMP2 (0.74) | TDP1USP2HSD17B10HIF1ATSHR | |
| Water SCHEMBL537059 | 0.97 | MMP2 (0.72) | TDP1USP2HSD17B10HIF1ATSHR | |
| Alcohol SCHEMBL14973542 | 0.94 | KDM4E (0.72) | TDP1USP2HSD17B10HIF1ATSHR | |
| SCHEMBL18610140 | 0.92 | TDP1 (0.65) | TDP1USP2HSD17B10HIF1ATSHR | |
| SCHEMBL21793722 | 0.85 | TDP1 (1.00) | TDP1USP2HSD17B10HIF1ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7449 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026060129-A9 | FORMULATIONS COMPRISING ENPP1 INHIBITORS | Petragen, Inc. (US) | 2026-05-21 | — | — | WO | claimed |
| WO-2026105164-A1 | NON-AQUEOUS LIQUID FORMULATIONS OF TETRACYCLINE ANTIBIOTICS | ETICO LIFESCIENCES PRIVATE LIMITED (IN) | 2026-05-21 | — | — | WO | claimed |
| US-20260139860-A1 | PRODUCTS OF MANUFACTURE FOR THE TREATMENT, PREVENTION AND AMELIORATION OF MICROBIAL INFECTIONS | CENTRE FOR DIGESTIVE DISEASES (AU) | 2026-05-21 | — | — | US | claimed |
| EP-3200748-B2 | COMPOSITIONS AND METHODS FOR THE TREATMENT AND PROPHYLAXIS OF SURGICAL SITE INFECTIONS | POLYPID LTD (IL) | 2026-04-15 | — | — | EP | claimed |
| US-20260091045-A1 | PREVENTATIVE MOUTHWASH CONTAINING DOXYCYCLINE AND METHOD OF PREVENTING COVID INFECTION USING THE PREVENTATIVE MOUTHWASH | ROSEMAN BRUCE (US) | 2026-04-02 | — | — | US | claimed |
| US-20260053823-A1 | PREVENTATIVE MOUTHWASH CONTAINING A SUB-ANTIMICROBIAL ORAL DOSAGE OF DOXYCYCLINE, METHOD OF PREVENTING COVID INFECTION USING THE MOUTHWASH, AND METHOD OF FORMULATING THE MOUTHWASH | ROSEMAN BRUCE (US) | 2026-02-26 | — | — | US | claimed |
| US-20260041701-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS OF MAKING ON DEMAND SOLID DOSAGE FORMULATIONS | EASTERN VIRGINIA MEDICAL SCHOOL (US) | 2026-02-12 | — | — | US | claimed |
| EP-4680248-A1 | PRODUCTS OF MANUFACTURE AND THERAPEUTIC COMPOSITIONS FOR TREATING, AMELIORATING OR PREVENTING VIRAL INFECTIONS AND METHODS FOR MAKING AND USING THEM | Topelia Aust Limited (ACN 652 771 670) (AU) | 2026-01-21 | — | — | EP | claimed |
| EP-4662203-A1 | BINDARIT CONJUGATES, COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES OR DISORDERS | Translatum Medicus Inc. (CA) | 2025-12-17 | — | — | EP | claimed |
| US-20250269005-A1 | METHODS FOR TREATING, AMELIORATING OR PREVENTING INFECTIONS USING DRUG AND VACCINATION COMBINATION TREATMENT | TOPELIA AUST LIMITED (ACN 652 771 670) (AU) | 2025-08-28 | — | — | US | claimed |
| EP-0374531-B1 | Method for the treatment of periodontal disease by sustained delivery of a therapeutic agent to the periodontal pocket, composition of matter therefor and apparatus for the administration thereof | AMERICAN CYANAMID CO (US) | 1994-05-04 | — | — | EP | claimed |
| WO-1993024154-A1 | BIODEGRADABLE CONTROLLED RELEASE MELT-SPUN DELIVERY SYSTEM | FUISZ TECHNOLOGIES, LTD. (US) | 1993-12-09 | — | — | WO | claimed |
| US-5188836-A | SUSTAINED RELEASE FORMULATIONS | WARNER-LAMBERT COMPANY (US) | 1993-02-23 | — | — | US | claimed |
| US-5167964-A | Coating of blend of ethyl acrylate-methacrylic acid copolymer and povidone | WARNER-LAMBERT COMPANY (US) | 1992-12-01 | — | — | US | claimed |
| US-5122519-A | Tetracyclines in solvent, gelling vehicle | AMERICAN CYANAMID COMPANY (US) | 1992-06-16 | — | — | US | claimed |
| WO-1992004902-A1 | BIODEGRADABLE GEL | MICRO VESICULAR SYSTEMS, INC. (US) | 1992-04-02 | — | — | WO | claimed |
| EP-0470047-A1 | Sustained release formulations | WARNER-LAMBERT COMPANY (US) | 1992-02-05 | — | — | EP | claimed |
| EP-0374531-A2 | Method for the treatment of periodontal disease by sustained delivery of a therapeutic agent to the periodontal pocket, composition of matter therefor and apparatus for the administration thereof | AMERICAN CYANAMID COMPANY (US) | 1990-06-27 | — | — | EP | claimed |
| EP-0337733-A2 | Single dose intramuscular treatment of chlamydia trachomatis infections | PFIZER INC. (US) | 1989-10-18 | — | — | EP | claimed |
| US-4678512-A | Marine coating compositions and method | GRAMS RALPH R | 1987-07-07 | — | — | US | claimed |